FiercePharma

The Oral GLP-1 Tracker: Lilly’s Foundayo scripts tick up amid overall obesity market slowdown

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
MarketWatch

U.S. 1 Month Treasury Bill

U.S. 3 Year Treasury Note-0.0250 4.2250% U.S. 5 Year Treasury Note-0.0140 4.2890% U.S. 7 Year Treasury Note-0.0100 4.4120% ...
NPR

1A

Listening to the news can feel like a journey. But 1A guides you beyond the headlines – and cuts through the noise. Let's get to the heart of the story, together – on 1A.